1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(10). p.1849-1863(
- Contribution to journal › Article
-
Mark
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
(
- Contribution to journal › Article
-
Mark
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
(
- Contribution to journal › Article
- 2021
-
Mark
Disseminated tumour cells from the bone marrow of early breast cancer patients : Results from an international pooled analysis
(
- Contribution to journal › Article
-
Mark
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
(
- Contribution to journal › Article
-
Mark
Combined associations of a polygenic risk score and classical risk factors with breast cancer risk
(
- Contribution to journal › Article
-
Mark
Breast cancer risk factors and survival by tumor subtype : pooled analyses from the Breast Cancer Association Consortium
2021) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30(4). p.623-642(
- Contribution to journal › Article
- 2016
-
Mark
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
2016) In Nature Genetics(
- Contribution to journal › Article
-
Mark
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
(
- Contribution to journal › Article
-
Mark
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
(
- Contribution to journal › Article